Cost-effectiveness of using artificial intelligence versus polygenic risk score to guide breast cancer screening. Mital S, Nguyen HV. BMC Cancer 2022;22:501.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mital S, Nguyen HV. Cost-effectiveness of using artificial intelligence versus polygenic risk score to guide breast cancer screening. BMC Cancer 2022;22:501.
PMID: 35524200